AzTrials
AzTrials

StrokeNCT07272759

Feasibility Study of Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program Among People With Stroke in Bang

A study testing Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program in people with Stroke, run by Tokyo Metropolitan University at 1 site in Bangladesh.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Stroke causes major disability issues in Bangladesh and often leaves people unable to look after themselves, work, or participate in family and community life. Most stroke survivors in Bangladesh do not receive adequate rehabilitation, and existing services focus mainly on physical exercises, not on helping people… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Stroke
What is being tested?
Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteBangladesh
Study dates
20 Oct 2025to 30 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18-64 years,
  • Diagnosed with stroke (ischemic/hemorrhagic) 3-24 months prior,
  • Medically stable and able to provide informed consent,
  • MoCA score ≥18.

Who cannot join

  • Severe receptive aphasia,
  • Major psychiatric disorders,
  • Unstable medical conditions

Trial locations and contacts

1 site in 1 country.

Bangladesh1 site
  • Centre for the Rehabilitation of the Paralysed (CRP)

    Dhaka

Other trials in Bangladesh

About this study

Stroke causes major disability issues in Bangladesh and often leaves people unable to look after themselves, work, or participate in family and community life. Most stroke survivors in Bangladesh do not receive adequate rehabilitation, and existing services focus mainly on physical exercises, not on helping people return to meaningful activities.

The REAP programme is a new therapy approach that remediates skills through structured training, educates patients and families on stroke management, adapts tasks or environments to make daily activities easier, and promotes participation in meaningful roles and activities.

This study will test whether the REAP programme can be delivered successfully in a Bangladeshi rehabilitation centre, whether patients find it acceptable, and whether it helps people become more independent and improves quality of life.

Conditions
Stroke
Being tested
Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) ProgramOther

    The REAP program consists of four core components designed to address the complex needs of stroke survivors:

    1. Remediation
    2. Education
    3. Adaptation
    4. Promotion
Study groups in NCT07272759
Study groupRoleWhat they receive
Stroke patients who are taking rehabilitationExperimentalStroke patients aged 18-64 years, diagnosed with stroke (ischemic/hemorrhagic) 3-6 months prior, medically stable and able to provide informed consent, MoCA score ≥18.
Receives: Other: Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Barthel Index

    Assesses independence in activities of daily living (ADLs).

    Measured: From enrollment to 12 weeks

  2. Montreal Cognitive Assessment (MoCA)

    Screens for cognitive impairment.

    Measured: Enrollment to 12 weeks

  3. Bangladeshi Occupational Self-Assessment - Short Form (BOSA-SF) (

    Evaluates perceived occupational competence and values within the local context.

    Measured: Enrollment to 12 weeks

  4. Fugl-Meyer Assessment (FMA)

    Assesses motor recovery post-stroke

    Measured: Enrollment to 12 weeks

  5. Occupational Balance Questionnaire

    Measures balance between different occupational areas in everyday life.

    Measured: Enrollment to 12 weeks

  6. Life Satisfaction Questionnaire (LiSat-11)

    Assesses subjective life satisfaction across various domains

    Measured: Enrollment to 12 weeks

  7. Zarit Caregiver Burden Scale

    Assesses the level of burden experienced by informal caregivers

    Measured: Enrollment to 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2025
  2. Study start20 Oct 2025
  3. Primary completion20 Dec 2025 (estimated)
  4. Study completion30 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07272759
Sponsor's protocol ID
CRP-ERC-R&E-0401-0479
Status last verified
Nov 2025
First submitted
26 Nov 2025
Last updated
9 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program in people with Stroke, run by Tokyo Metropolitan University at 1 site in Bangladesh.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bangladesh. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Barthel Index (time frame: From enrollment to 12 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in